Related Experiment Videos
Anti-cholesterol antibodies in human sera
1Third Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary. horann@kut.sote.hu
Autoimmunity Reviews
|September 11, 2003
Summary
High cholesterol is a risk for atherosclerosis. Research shows anti-cholesterol antibodies (ACHA) may play a role in preventing this condition in humans, similar to animal studies.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Biochemistry
Background:
- High serum cholesterol levels are a known risk factor for atherosclerosis.
- Recent research highlights the significant role of the immune system in atherosclerosis development and progression.
- The immune system possesses the capacity to bind to cholesterol.
Purpose of the Study:
- To investigate whether anti-cholesterol antibodies (ACHA) have a similar preventative function against atherosclerosis in humans as observed in animal models.
- To summarize studies examining ACHA levels in human sera.
Main Methods:
- Measurement of serum ACHA levels in various patient groups: those with atherosclerotic diseases, those with viral infections, and healthy individuals.
- Review of existing studies on ACHA in human sera.
Main Results:
- Serum ACHA levels were measured across different human populations.
- The study aimed to correlate ACHA levels with atherosclerotic conditions.
Conclusions:
- The review summarizes findings on ACHA in human sera.
- Potential functions of ACHA within the human immune system in relation to atherosclerosis are discussed.